5 completed, 2 terminated. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 2 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow George Albert Fisher: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer Epacadostat, Pembrolizumab - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Completed | George Albert Fisher | 3 | 2017-09-13 | 2024-01-23 |
| A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma Pertuzumab, Erlotinib - Pancreatic Cancer | Phase 2 | Terminated | George Albert Fisher | 1 | 2010-07-01 | 2017-03-03 |
| Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer Lapatinib, Doxorubicin, Cyclophosphamide - Breast Cancer, Metastatic Breast Cancer | Phase 2 | Completed | George Albert Fisher | 21 | 2006-10-01 | 2017-12-22 |
| Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer Gemcitabine, Paclitaxel, Bevacizumab - Breast Cancer, Metastatic Breast Cancer | Phase 2 | Completed | George Albert Fisher | 31 | 2006-02-01 | 2019-02-20 |
| Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer Gemcitabine, Dendritic Cell Immunotherapy - Pancreatic Cancer | Phase 1 | Completed | George Albert Fisher | 2 | 2005-10-01 | 2012-11-08 |
| Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer Vatalanib, Gemcitabine - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | George Albert Fisher | 33 | 2004-10-01 | 2014-09-15 |
| A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Cetuximab, Oxaliplatin, Capecitabine - Rectal Cancer, Colo-rectal Cancer | Phase 1 / Phase 2 | Terminated | George Albert Fisher | 23 | 2004-06-01 | 2017-12-08 |
Pancreatic Neoplasms (3) · Breast Neoplasms (2) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Rectal Neoplasms (1) · Stomach Neoplasms (1)
Gemcitabine (3) · Bevacizumab (1) · Calcium Dobesilate (1) · Capecitabine (1) · Cetuximab (1) · Cyclophosphamide (1) · Dexamethasone (1) · Diphenhydramine (1) · Docetaxel (1) · Doxorubicin (1) · Doxylamine (1) · Erlotinib Hydrochloride (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Lapatinib (1)
United States (7)
George A Fisher, MD, PhD (3) · George Albert Fisher M.D. Ph.D. (3) · Branimir I Sikic, MD (1) · Edgar G Engleman (1) · George A Fisher, MD (1)